Dow Up 1.63% Nasdaq Up 0.97%

DexCom, Inc. (DXCM)

-NasdaqGS
40.66 Oct 17, 4:00PM EDT
Prev Close:40.66
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:44.27
Beta:-0.03
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:N/A - N/A
52wk Range:27.10 - 49.83
Volume:0
Avg Vol (3m):640,240
Market Cap:3.07B
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DXCM 0.00%3.07B
MDT60.72B

Key Statistics

Forward P/E (1 yr):580.86
P/S (ttm):15.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-3.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in th... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback